Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

There are improved all-cause mortality, rhythm control, and adverse cardiac event outcomes in patients being treated with tirzepatide who have atrial fibrillation. Patients with atrial ...

Oral semaglutide (Rybelsus) can be tied to a near halving of incident Afib, according to a meta-analysis of 26 randomized ...

Stroke, one of the most severe complications of atrial fibrillation (AF), can be prevented by oral anticoagulants in patients ...

This algorithm increases the pacing rate when the native rhythm emerges and ... symptomatic AF burden by 25% (2.50% control vs. 1.87% treatment). Atrial fibrillation burden decreased progressively ...

Canada-based Kardium has revealed positive one-year efficacy results on its pulsed field ablation (PFA) device, the Globe PF ...

GLP-1 use significantly lowered risk for atrial fibrillation-related events for patients with diabetes, AF and obesity, with ...

Discover how alcohol silently damages your brain, heart, pancreas, and other critical organs beyond the liver, with effects ...

For medically refractory vasovagal syncope (VVS) and functional bradycardia, the feasibility of off-label catheter ...